Technological advancements have enabled no-wash/no-lyse workflows for more precise and faster flow cytometry analysis. No-wash/no-lyse workflows have been used to generate accurate, reproducible ...

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to enable and facilitate robotic arm integration with BD flow cytometry ...

Designing multicolor panels and operating flow cytometry experiments is complex and vulnerable to human error. However, you don’t have to be an expert in flow ...

7 A work recently published in Diagnostics developed and validated AI-assisted flow cytometry workflow for primary immunodeficiency diseases and related immunological disorders using 379 clinical ...

This handbook is designed as a go-to reference for every flow cytometry user. Scientists using traditional systems will learn how routine workflows can benefit from the speed, throughput, and ...

Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...

Traditionally, several steps in a lab’s flow cytometry workflow for drug discovery and development require manual processes. With robotic integration, these steps can become automated.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today ...

FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...